| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |